Genocea Biosciences Company
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
Industry:
Atrificial Vectors and Immune Cells
Last Funding Type:
Post-IPO Equity
Funding Status:
IPO
Estimated Revenue:
$10M to $50M
Total Funding:
470569774
Investors Number:
13
Headquarters:
Cambridge, Massachusetts, United States
Last Funding Date:
2020-07-22
Founded Date:
2006-01-01
Employee Number:
51-100